CMCIX
Price
$26.88
Change
+$0.19 (+0.71%)
Updated
Jul 25 closing price
Net Assets
29.8M
VEXRX
Price
$108.38
Change
+$0.80 (+0.74%)
Updated
Jul 25 closing price
Net Assets
20.12B
Interact to see
Advertisement

CMCIX vs VEXRX

Header iconCMCIX vs VEXRX Comparison
Open Charts CMCIX vs VEXRXBanner chart's image
Calvert Small/Mid-Cap I
Price$26.88
Change+$0.19 (+0.71%)
VolumeN/A
Net Assets29.8M
Vanguard Explorer Adm
Price$108.38
Change+$0.80 (+0.74%)
VolumeN/A
Net Assets20.12B
CMCIX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CMCIX vs. VEXRX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMCIX is a Buy and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.1B vs. CMCIX (29.8M). VEXRX pays higher dividends than CMCIX: VEXRX (0.52) vs CMCIX (0.40). CMCIX was incepted earlier than VEXRX: CMCIX (14 years) vs VEXRX (24 years). CMCIX (0.96) is less costly to investors than VEXRX (0.33). CMCIX is a more actively managed with annual turnover of: 42.00 vs. VEXRX (35.00). VEXRX has a lower initial minimum investment than CMCIX: VEXRX (50000) vs CMCIX (1000000). VEXRX annual gain was more profitable for investors over the last year : -0.86 vs. CMCIX (-1.25). CMCIX return over 5 years is better than : 16.85 vs. VEXRX (11.61).
CMCIXVEXRXCMCIX / VEXRX
Total Expense Ratio0.900.33273%
Annual Report Gross Expense Ratio0.960.33291%
Fund Existence14 years24 years-
Gain YTD0.0371.4323%
Front LoadN/AN/A-
Min. Initial Investment1000000500002,000%
Min. Initial Investment IRAN/AN/A-
Net Assets29.8M20.1B0%
Annual Yield % from dividends0.400.5276%
Returns for 1 year-1.25-0.86145%
Returns for 3 years11.3517.6164%
Returns for 5 years16.8511.61145%
Returns for 10 years12.1321.1557%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OTLC0.05N/A
+0.49%
Oncotelic Therapeutics, Inc.
AMDUF80.95N/A
N/A
AMUNDI SA
HNFSA45.00N/A
N/A
Hanover Foods Corp.
TRKNY2.88N/A
N/A
Turk Telekomunikasyon
CRECF0.32-0.01
-2.47%
Critical Elements Lithium Corporation